ririРаны и раневые инфекции. Журнал имени проф. Б.М. КостючёнкаWounds and wound infections. The prof. B.M. Kostyuchenok journal2408-96132500-0594Regional non-governmental organization “Surgical society - Wounds and wound infections”10.25199/2408-9613-2021-8-3-24-32riri-254Research ArticleОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯORIGINAL RESEARCHЛечение сложных ран гидроволокнистыми перевязочными средствами в условиях городской больницы Боготы (Колумбия)Management of complex wounds treatment with a hydrofiber dressing in a public hospital in Bogota (Colombia)Салазар ТрухильоМ. А.Salazar TrujilloM. A.

Марко Антонио Салазар Трухильо - кафедра пластической хирургии факультета последипломного образования.

056458, Боливар, ул. Эль Боск, д. 729

Department of Postgraduate Education in Plastic Surgery.

729 El Bosque Av., Bolivar, 056458

marcosalazart@hotmail.comУниверситет Сину КолумбияКолумбияSinu UniversityColombia202126112021832634Copyright © Салазар Трухильо М.А., 20212021Салазар Трухильо М.А.Salazar Trujillo M.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.riri.su/jour/article/view/254

Цель исследования — оценка эффективности использования перевязочных средств из гидроволокна (технология Гидрофайбер®) последнего поколения с серебром для лечения сложных ран.

Материалы и методы исследования. Проведено проспективное клиническое исследование, в которое были включены пациенты с острыми или хроническими плохо заживающими ранами, лечившиеся в отделении пластической хирургии государственной больницы Боготы, Колумбия. В местном лечении использовали раневые покрытия на основе Гидрофайбер®, прошитые усиленным волокном и содержащие ионы серебра, хлорид бензетония и ЭДТА (Aquacel™Agplus, ConvaTec). Следили за динамикой теченияра-невого процесса, оценивая степень воспаления, экссудацию, наличие биопленок, а также количество требуемых перевязок и сроки, необходимые для полного заживления раны.

Результаты исследования

Результаты исследования. Всего было включено 55пациентов, средний возраст которых составил 44 года. Во всех случаях наблюдение проводили до полного заживления раны. В конце исследования было замечено, что у 35 (63,6 %) пациентов раны полностью зажили вторичным натяжением в среднем за 59,3 сут, что потребовало 12,5 перевязок. У20 (36,4 %) больных раневая поверхность была подготовлена к пластике с использованием трансплантатов, лоскутов или кожных эквивалентов в среднем к 31,4 сут, что потребовало в среднем 6,5 перевязок.

Раны 33 (60,0 %) пациентов были инфицированы, адекватный контроль над инфекцией достигался в среднем через 5 перевязок. Уменьшение прямых и косвенных признаков наличия в ранах биопленок наблюдали после 6 перевязок.

Заключение

Заключение. Полученные результаты показывают эффективность перевязочных средств из гидроволокна (технология Гидрофайбер®) последнего поколения с серебром для удаления избыточного экссудата и биопленок, контроля над инфекционным процессом в ране, а также при подготовке раневого ложа к окончательному хирургическому вмешательству.

Objective

Objective. To evaluate the efficacy of the use of a last generation hydrofiber dressing with silver, for the treatment of complex wounds that are difficult to heal.

Materials and research methods. A prospective observational case-follow-up study was carried out, which included patients with acute or chronic wounds that were difficult to heal, treated in the plastic surgery service of a public hospital in Bogota-Colombia, who underwent healing with hydrofiber dressings reinforced, with silver ions, benzethonium chloride and EDTA (Aquacel Agplus®, ConvaTec). The wound was monitored, evaluating infection control, exudate and biofilm, as well as the number of required dressings and the time required for the complete closure of the wound.

Research results

Research results. A total of 55 patients were included, with a median age of 44 years. In all cases, a follow-up was carried out until the definitive closure of the wound. At the end of the study, it was observed that, in 35 (63.6 %) patients, the wounds evolved to complete closure by second intention in an average of 59.3 days, requiring 12.5 dressings. 20 (36.4 %) patients had adequate wound bed preparation for definitive surgical coverage with grafts, flaps or dermal substitutes, in an average of 31.4 days, requiring 6.5 dressings on average.

33 (60

33 (60.0 %) wounds were infected and adequate infection control was achieved on average with 5 dressings. A decrease in the direct and indirect signs of biofilm was achieved after 6 dressings.

Conclusion

Conclusion. The results show that the dressing studied is effective to control exudate, infection and biofilm, as well as to prepare the bed for a definitive surgical coverage.

сложные раныхронические раныповязки с серебромгидрофайбербиопленкихирургическое лечениеместное лечениеcomplex woundschronic woundssilver dressingshydrofiberbiofilmssurgical treatmentlocal treatmentReferencesAtiyeh B. S., Ioannovich J., Al-Amm C. A., EI-Musa K. A. Management of acute and chronic open wounds: the importance of moist environment in optimal wound healing. Curr Pharm Biotechnol. 2002; 3 (3): 179-195.Atiyeh B. S., Ioannovich J., Al-Amm C. A., EI-Musa K. A. Management of acute and chronic open wounds: the importance of moist environment in optimal wound healing. Curr Pharm Biotechnol. 2002; 3 (3): 179-195.Troxler M., Vowden K., Vowden P. Integrating adjunctive therapy into practice: The importance of recognosing “hard to heal” wounds. World Wide Wounds. 2005.Troxler M., Vowden K., Vowden P. Integrating adjunctive therapy into practice: The importance of recognosing “hard to heal” wounds. World Wide Wounds. 2005.Margolls D. J., Allen-Taylor L., Hoffstad O., Berlin J. A. The Accuracy of venous leg ulcer prognostic models in a wound care system. Wound repair regen. 2004; 12 (2):163-68.Margolls D. J., Allen-Taylor L., Hoffstad O., Berlin J. A. The Accuracy of venous leg ulcer prognostic models in a wound care system. Wound repair regen. 2004; 12 (2):163-68.Phillips T. J., Machedo F., Trout R., et al. Prognostic indicators in venous ulcers. Am Acad Dermatol. 2000; 43 (4): 627630.Phillips T. J., Machedo F., Trout R., et al. Prognostic indicators in venous ulcers. Am Acad Dermatol. 2000; 43 (4): 627630.Schultz G. S., Sibbald R. G., Falanga V., et al. Wound bed preparation: a systematic approach to wound management. Wound Repair Regen. 2003; 11 (Suppl 1): S1.Schultz G. S., Sibbald R. G., Falanga V., et al. Wound bed preparation: a systematic approach to wound management. Wound Repair Regen. 2003; 11 (Suppl 1): S1.Gompelman M., van Asten S. A. V., Peters E. J. G. Update on the Role of Infection and Biofilms in Wound Healing: Pathophysiology and Treatment. Plast Reconstr Surg. 2016; 138 (3S): 61S-70S.Gompelman M., van Asten S. A. V., Peters E. J. G. Update on the Role of Infection and Biofilms in Wound Healing: Pathophysiology and Treatment. Plast Reconstr Surg. 2016; 138 (3S): 61S-70S.Metcalf D. G., Bowler P. G., Hurlow J. A clinical algorithm for wound biofilm identification. J Wound Care. 2014; 23 (3):137—142.Metcalf D. G., Bowler P. G., Hurlow J. A clinical algorithm for wound biofilm identification. J Wound Care. 2014; 23 (3):137—142.Patel R. Biofilms and Antimicrobial Resistance. Clin Orthop Related Res. 2005; (437): 41—47.Patel R. Biofilms and Antimicrobial Resistance. Clin Orthop Related Res. 2005; (437): 41—47.Hurlow J., Bowler P. G. Clinical experience with wound biofilm and management: a case series. Ostomy Wound Manage. 2009; 55 (4): 38—49.Hurlow J., Bowler P. G. Clinical experience with wound biofilm and management: a case series. Ostomy Wound Manage. 2009; 55 (4): 38—49.Hurlow J., Bowler P. G. Potential implications of biofilm in chronic wounds: a case series. J Wound Care. 2012; 21(3): 109—119.Hurlow J., Bowler P. G. Potential implications of biofilm in chronic wounds: a case series. J Wound Care. 2012; 21(3): 109—119.Wolcott R. D., Rumbaugh K. P., James G., et al. Biofilm maturity studies indicate sharp debridement opens a time- dependent therapeutic window. J Wound Care 2010; 19(8):320—328.Wolcott R. D., Rumbaugh K. P., James G., et al. Biofilm maturity studies indicate sharp debridement opens a time- dependent therapeutic window. J Wound Care 2010; 19(8):320—328.Metcalf D., Parsons D., Woo K. Next-generation antimicrobial dressings: AQUACELTM Ag+ ExtraTM and Ribbon. Wounds International. 2014; 5: Sup-pl.Metcalf D., Parsons D., Woo K. Next-generation antimicrobial dressings: AQUACELTM Ag+ ExtraTM and Ribbon. Wounds International. 2014; 5: Sup-pl.Bowler P. G., Welsby S., Towers V., et al. Multidrug-resistant organisms, wounds and topical antimicrobial protection. Int Wound J. 2012; 9 (4): 387—396.Bowler P. G., Welsby S., Towers V., et al. Multidrug-resistant organisms, wounds and topical antimicrobial protection. Int Wound J. 2012; 9 (4): 387—396.Bowler P. G., Jones S. A., Walker M., et al. Microbicidal properties of a silver-containing hydrofiber dressing against a variety of burn wound pathogens. J Burn Care Rehabil. 2004; 25 (2): 192—196.Bowler P. G., Jones S. A., Walker M., et al. Microbicidal properties of a silver-containing hydrofiber dressing against a variety of burn wound pathogens. J Burn Care Rehabil. 2004; 25 (2): 192—196.Jones S. A., Bowler P. G., Walker M., Parsons D. Controlling wound bioburden with a novel silver-containing Hydrofiber dressing. Wound Repair Regen. 2004; 12(3): 288—294.Jones S. A., Bowler P. G., Walker M., Parsons D. Controlling wound bioburden with a novel silver-containing Hydrofiber dressing. Wound Repair Regen. 2004; 12(3): 288—294.The broad spectrum activity of FAB Ag using a corrected zone of inhibition assay. Scientific Background Report, WHRI3609 MA194. 2012. Data on file, ConvaTec.The broad spectrum activity of FAB Ag using a corrected zone of inhibition assay. Scientific Background Report, WHRI3609 MA194. 2012. Data on file, ConvaTec.Assessment of the physical disruption of biofilm by the application of FAB Ag. Scientific Background Report, WHRI3682 TA256. 2012. Data on file, ConvaTec.Assessment of the physical disruption of biofilm by the application of FAB Ag. Scientific Background Report, WHRI3682 TA256. 2012. Data on file, ConvaTec.The antimicrobial activity of FAB Ag against surface-attached bacteria. Scientific Background Report, WHRI3636 MA206. 2012. Data on file, ConvaTec.The antimicrobial activity of FAB Ag against surface-attached bacteria. Scientific Background Report, WHRI3636 MA206. 2012. Data on file, ConvaTec.Prevention of bacterial attachment by FAB Ag (EASH, DHF#707). Scientific Background Report, WHRI3635 MA205. 2012. Data on file, ConvaTec.Prevention of bacterial attachment by FAB Ag (EASH, DHF#707). Scientific Background Report, WHRI3635 MA205. 2012. Data on file, ConvaTec.Seth A. K., Zhong A., Nguyen K. T., et al. Impact of a novel, antimicrobial dressing on in vivo, Pseudomonas aeruginosa wound biofilm: quantitative comparative analysis using a rabbit ear model. Wound Repair Regen. 2014; 22 (6): 712— 719.Seth A. K., Zhong A., Nguyen K. T., et al. Impact of a novel, antimicrobial dressing on in vivo, Pseudomonas aeruginosa wound biofilm: quantitative comparative analysis using a rabbit ear model. Wound Repair Regen. 2014; 22 (6): 712— 719.Visualization of the speed of kill by FAB Ag using a confocal microscope. Scientific Background Report, WHRI3617 MA199. 2012. Data on file, ConvaTec.Visualization of the speed of kill by FAB Ag using a confocal microscope. Scientific Background Report, WHRI3617 MA199. 2012. Data on file, ConvaTec.Parsons D. Composition comprising antimicrobial metal ions and a quaternary cationic surfactant. 2012. https://tinyurl.com/twz5yfzParsons D. Composition comprising antimicrobial metal ions and a quaternary cationic surfactant. 2012. https://tinyurl.com/twz5yfzCeri H., Olson M. E., Stremick C., et al. The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol. 1999; 37 (6): 1771—1776.Ceri H., Olson M. E., Stremick C., et al. The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol. 1999; 37 (6): 1771—1776.Gurjala A. N., Geringer M. R., Seth A. K., et al. Development of a novel, highly quantitative in vivo model for the study of biofilm-impaired cutaneous wound healing. Wound Repair Regen. 2011; 19 (3): 400—410.Gurjala A. N., Geringer M. R., Seth A. K., et al. Development of a novel, highly quantitative in vivo model for the study of biofilm-impaired cutaneous wound healing. Wound Repair Regen. 2011; 19 (3): 400—410.Metcalf D. G., Parsons D., Bowler P. G. Clinical safety and effectiveness evaluation of a new antimicrobial wound dressing designed to manage exudate, infection and biofilm. Int Wound J. 2017; 14 (1): 203—213.Metcalf D. G., Parsons D., Bowler P. G. Clinical safety and effectiveness evaluation of a new antimicrobial wound dressing designed to manage exudate, infection and biofilm. Int Wound J. 2017; 14 (1): 203—213.Murphy C., Atkin L., Swanson T., et al. International consensus document. Defying hard-to-heal wounds with an early antibioflm intervention strategy: wound hygiene. J Wound Care. 2020; 29 (Suppl 3b): S1—S28.Murphy C., Atkin L., Swanson T., et al. International consensus document. Defying hard-to-heal wounds with an early antibioflm intervention strategy: wound hygiene. J Wound Care. 2020; 29 (Suppl 3b): S1—S28.

The authors declare that there are no conflicts of interest present.